Home/Filings/4/0001209191-22-025719
4//SEC Filing

Sims Andrew John Hugh MacIntyre 4

Accession 0001209191-22-025719

CIK 0001095981other

Filed

Apr 26, 8:00 PM ET

Accepted

Apr 27, 7:00 AM ET

Size

4.8 KB

Accession

0001209191-22-025719

Insider Transaction Report

Form 4
Period: 2022-04-26
Sims Andrew John Hugh MacIntyre
Chief Financial Officer
Transactions
  • Purchase

    Common Stock

    2022-04-26$0.67/sh+3,000$2,01612,230 total

Issuer

PLUS THERAPEUTICS, INC.

CIK 0001095981

Entity typeother

Related Parties

1
  • filerCIK 0001802687

Filing Metadata

Form type
4
Filed
Apr 26, 8:00 PM ET
Accepted
Apr 27, 7:00 AM ET
Size
4.8 KB